Colorectal Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Mar 07, 2019
- Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
Sokic-Milutinovic Aleksandra et al. Digestive diseases (Basel, Switzerland) 2019 Mar 1-6 - Exome sequencing in 51 early onset non-familial CRC cases.
Thutkawkorapin Jessada et al. Molecular genetics & genomic medicine 2019 Feb e605 - Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.
Turbitt Erin et al. Preventive medicine 2019 Feb 12312-19 - Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
Franczak Claire et al. PloS one 2019 14(2) e0212801 - Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi Keisuke et al. European journal of cancer (Oxford, England : 1990) 2019 Feb 11182-93 - The apparent genetic anticipation in PMS2-associated Lynch syndrome families is explained by birth cohort effect.
Ten Broeke Sanne W et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Mar - [A single center study of colorectal cancer screening for Lynch syndrome].
Pan Jie et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Mar 36(3) 238-241 - An Experience of Implementation and Outcomes of Universal Testing for Lynch Syndrome in the United Kingdom.
Cavazza A et al. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2019 Feb - [Lynch Syndrome:Report of One Case and Literature Review].
Guo Yan-Ping et al. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2018 Jun 40(3) 432-435 - Precision medicine becomes reality-tumor type-agnostic therapy.
Yan Li et al. Cancer communications (London, England) 2018 38(1) 6 - RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
Yao Jiannan et al. Canadian journal of gastroenterology & hepatology 2018 20184248971 - Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer Florian et al. BMC cancer 2018 18(1) 11 - What Are the Symptoms of Colorectal Cancer?
CDC, 2019 - A Review of the Management of Sporadic Colorectal Adenomas in Young People: Is Surveillance Wasted on the Young?
Bushyhead Daniel et al. Digestive diseases and sciences 2019 Feb - BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer.
Shimada Yoshifumi et al. Scientific reports 2019 Feb 9(1) 2466
No hay comentarios:
Publicar un comentario